PureBioX H-1B Visa Sponsorship 2026
Research and Development in Biotechnology Β· H-1B sponsor Β· FY2017β2026
π’ St. Paul, MN HQπ purebiox.com
Does PureBioX sponsor H-1B visas?
Yes. PureBioX has filed 6 H-1B LCAs with the U.S. Department of Labor in FY2026. In FY2025β2026 PureBioX filed 6 H-1B LCAs at a median base salary of $92,914, about 24% below the national H-1B median of $121,966 for the same period. No PERM green-card cases are on record.
It files most often for Analytical Chemist roles, most in St. Paul, MN.
H-1B filings
6 H-1B filings in FY2026, median base salary $93k. Too few years to chart a trend.
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
Where they hire
Worker backgrounds
From green-card (PERM) cases
Sponsors H-1B workers but has few or no green-card (PERM) cases under this name, so worker backgrounds arenβt available.
Pay against the local market
PureBioXβs most-filed occupations and metros, FY2026. Its median base salary is 92% of the local BLS median for the same work.
| Occupation | Metro | Filings | PureBioX pay | Local BLS medianβ‘ | vs market |
|---|---|---|---|---|---|
| Bioengineers and Biomedical Engineers | Minneapolis, MN | 2 | $92,914 | $126,780 | 73% |
| Chemists | Minneapolis, MN | 2 | $92,914 | $83,790 | 111% |
About PureBioX
- Name (DOL filings)
- PureBioX, Inc.
- Listed
- β
- Sponsoring since
- FY2026
- Main filing location
- St. Paul, MN
- Industry
- Pharma & biotech
- Website
- purebiox.com
- H-1B filings
- 6
- Median base
- $92,914
- R&D
- β
H-1B sponsors similar to PureBioX
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Antares Pharma | 8 | 3 | $140k | 0 | β |
| Avidity Biosciences | 8 | 4 | $125k | 1 | β |
| Cellbae | 8 | 4 | $78k | 1 | β |
| PureBioX | 6 | 6 | $93k | 0 | β |
| Asklepion Pharmaceuticals | 6 | 1 | $500k | 0 | β |
| Bioalgo | 6 | 1 | $113k | 0 | β |
| Connect Biopharm | 6 | 2 | $140k | 0 | β |
